CAS 78473-10-6
:2-amino-3,5-dicyanopyridinium
2-Aminopyridine-3,5-dicarbonitrile
CAS :Formule :C7H4N4Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :144.13352-Aminopyridine-3,5-dicarbonitrile
CAS :2-Aminopyridine-3,5-dicarbonitrileDegré de pureté :97%Masse moléculaire :144.14g/mol2-aminopyridine-3,5-dicarbonitrile
CAS :Formule :C7H4N4Degré de pureté :≥97%Couleur et forme :SolidMasse moléculaire :144.1372-Amino-3,5-pyridinedicarbonitrile
CAS :Produit contrôléFormule :C7H4N4Couleur et forme :NeatMasse moléculaire :144.1332-Amino-3,5-pyridinedicarbonitrile
CAS :2-Amino-3,5-pyridinedicarbonitrile (APDC) is a small molecule that has been shown to bind to the adenosine A1 receptor with high affinity and selectivity. It has a molecular weight of 167.2 g/mol, a pK of 7.4 and a logP value of 2.8. APDC was first synthesized in 1963 by scientists at the National Institute for Medical Research in London. The chlorine atom is influential in the pharmacokinetics of this compound. The pharmacokinetic profile shows that APDC is poorly absorbed and eliminated quickly from the body, with an elimination half-life of 0.6 hours and an oral bioavailability of less than 1%. This drug also has multipotent effects on Alzheimer's disease, showing significant efficacy against both plaques and tangles in animal models of Alzheimer's disease.
Formule :C7H4N4Degré de pureté :Min. 95%Masse moléculaire :144.13 g/mol




